Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$443,138
+$63,183 QoQ
Shares Held
1,761
+0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#3,280
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEIGH BALDWIN & CO., LLC holds $5,076,288 across 8 Drug Manufacturers - General names. ABBV ranks #7 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,112 | $1,333,766 | |
| 2 | MRK |
Merck & Co., Inc.
|
5,407 | $694,799 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
4,769 | $602,515 | |
| 4 | JNJ |
Johnson & Johnson
|
2,262 | $574,480 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
9,200 | $530,104 | |
| 6 | PFE |
Pfizer Inc
|
19,135 | $460,770 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
1,761 | $443,138 | |
| 8 | AMGN |
Amgen Inc
|
1,206 | $436,716 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $443,138 | 1,761 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $379,955 | 1,747 | Shares | Sole | 2026-05-20 | |
| 2025-12-31 | $388,889 | 1,702 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $398,711 | 1,722 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $256,898 | 1,384 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $400,811 | 1,913 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $309,020 | 1,739 | Shares | Sole | 2025-02-25 | |
| No filing history on record for this holder in this stock. | ||||||